MYLAN ApS: Financial statements 2017
CVR: 28107013
Source: annual report 2017, Danish Business Authority
01/01/2017 – 31/12/2017
MYLAN ApS (CVR 28107013) has filed annual accounts for 2017. In 2017, the company reported a gross profit of DKK 2,217 and a net result of DKK 1,702 compared with DKK 2,217 the year before. That is a decrease of 14.1% compared with the year before. Equity in the 2017 report amounted to DKK 186,315. The solvency ratio was 52.1%.
- Gross Profit
- DKK 2,217
- Profit/Loss
- DKK 1,702
- Equity
- DKK 186,315
- Total Assets
- DKK 357,688
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2017 | - | 2 t. | 2 t. | 186 t. | 0 |
| 2016 | - | 3 t. | 2 t. | 185 t. | - |
| 2015 | - | - | 0 | 0 | - |
| 2014 | - | - | 0 | 0 | - |
| 2013 | - | -3 t. | -2 t. | -178 t. | - |
Keep an eye on MYLAN ApS
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2017
As of September 5, 2017, Anthonius Matthijs van 't Hullenaar has joined the board of directors of MYLAN ApS.
As of September 5, 2017, Jean-Yves Brault has left the board of directors of MYLAN ApS.
MYLAN ApS has published its annual report for 2016. Gross profit came to DKK 2,580, and the net result was DKK 2,217.
As of June 16, 2017, Gitte Jürgens has joined the board of directors of MYLAN ApS.
As of June 16, 2017, Jens Olof Frykman has left the board of directors of MYLAN ApS.
About MYLAN ApS
MYLAN ApS was a Danish company of the type Anpartsselskab based in Ballerup, founded in 2004. The company was registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named MERCK NM ApS and NM PHARMA ApS. In 2024, the company reported a gross profit of DKK 3,631 and a net result of DKK 3,137 compared with DKK 1,952 the year before. Equity in the 2024 report amounted to DKK 198,978.